According to the Washington Post, 13 states currently cover the drugs for Medicaid patients, while Medicare prohibits ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington ...

Advocates say many consumers might not be aware they are on Medicaid due to the program's frequent name changes.

Several companies, including Oracle and Microsoft, are expected to sign pledges to work on the Trump administration ...

A new rule issued by the Centers for Medicare and Medicaid Services will strip DACA recipients of eligibility for coverage ...

Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach for many obese Americans.

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...

OBBBA poses an immense stress test for both Community Health Centers and Medicaid. But over the decades, these programs have ...